Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  The Lancet

• Publication date

  2018-01-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0140-6736(17)32714-9PMID 29103656
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [2018 ESC/EACTS Guidelines on myocardial revascularization. The Task Force on myocardial revascularization of the European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery (EACTS)].

  2019cited by this paper
• Valuing health‐related quality of life: An EQ‐5D‐5L value set for England

  2017cited by this paper
• ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease

  2017cited by this paper
• ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association,

  2017cited by this paper
• ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2016 Appropriate Use Criteria for Coronary Revascularization in Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, Ameri

  2017cited by this paper
• GIANT RIGHT CORONARY ARTERY ANEURYSM ASSOCIATED WITH A CORONARY CAMERAL FISTULA TO THE RIGHT ATRIUM

  2017cited by this paper
• Management of Percutaneous Coronary Intervention Complications

  2017cited by this paper
• Informed Decision Making for Percutaneous Coronary Intervention for Stable Coronary Disease.

  2015cited by this paper
• National Institute for Health and Care Excellence.

  2015cited by this paper
• ESC / EACTS Guidelines on myocardial revascularization

  2014cited by this paper
• Use of placebo controls in the evaluation of surgery: systematic review

  2014cited by this paper
• 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous

  2014cited by this paper
• How cardiologists present the benefits of percutaneous coronary interventions to patients with stable angina: a qualitative analysis.

  2014cited by this paper
• Fractional flow reserve-guided PCI for stable coronary artery disease.

  2014cited by this paper
• Removing the hype from hypertension

  2014cited by this paper
• Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials.

  2014cited by this paper
• Frequency, Predictors, and Consequences of Crossing Over to Revascularization Within 12 Months of Randomization to Optimal Medical Therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial

  2013cited by this paper
• Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease.

  2012cited by this paper
• 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Ass

  2012cited by this paper
• Meta-analysis: Effects of Percutaneous Coronary Intervention Versus Medical Therapy on Angina Relief

  2010cited by this paper
• Fractional flow reserve versus angiography for guiding percutaneous coronary intervention.

  2009cited by this paper
• Effect of PCI on quality of life in patients with stable coronary disease.

  2008cited by this paper
• Optimal medical therapy with or without PCI for stable coronary disease.

  2007cited by this paper
• FOCUS ISSUE: CARDIAC INTERVENTION Intervention in Acute Coronary Syndromes Benefit of Early Invasive Therapy in Acute Coronary Syndromes A Meta-Analysis of Contemporary Randomized Clinical Trials

  2006cited by this paper
• European Association of Percutaneous Cardiovascular Interventions (EAPCI).

  2006cited by this paper
• Relationship of Serum Cardiac Markers following Successful Percutaneous Coronary Intervention and Subsequent Exercise Capacity in Patients with Chronic Stable Angina: A Pilot Study

  2005cited by this paper
• Assessment of blinding in clinical trials.

  2004cited by this paper
• Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina.

  2004cited by this paper
• Antianginal and Antiischemic Effects of Ivabradine, an If Inhibitor, in Stable Angina: A Randomized, Double-Blind, Multicentered, Placebo-Controlled Trial

  2003cited by this paper
• Anaerobic Threshold and Maximal Oxygen Uptake in Patients with Coronary Artery Disease and Stable Angina before and after Percutaneous Transluminal Coronary Angioplasty

  2002cited by this paper
• The UK version of the Seattle Angina Questionnaire (SAQ-UK): reliability, validity and responsiveness.

  2001cited by this paper
• Do medical devices have enhanced placebo effects?

  2000cited by this paper
• Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials.

  1995cited by this paper
• Concept of true and perceived placebo effects

  1995cited by this paper
• A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators.

  1992cited by this paper
• A Comparison of Angioplasty With Medical Therapy in the Treatment of Single-Vessel Coronary Artery Disease

  1992cited by this paper
• Exercise treadmill score for predicting prognosis in coronary artery disease.

  1987cited by this paper
• General practice consultations: is there any point in being positive?

  1987cited by this paper
• Transluminal dilatation of coronary-artery stenosis.

  1978cited by this paper
• Transluminal dilatation for coronary-artery stenosis.

  1978cited by this paper

• Percutaneous coronary intervention as an independent predictor of non-target lesion progression in 1658 patients with coronary artery disease

  2026cites this paper
• Estimating the Placebo Effect on Patient-Reported Outcomes in Sham-controlled Device Trials: Insights from REDUCE LAP-HF II.

  2026cites this paper
• Fractional flow reserve-guided percutaneous coronary intervention versus medical therapy for stable coronary artery disease: long-term results of the FAME 2 trial

  2026cites this paper
• Lubrication to reduce tissue shear loading - effects on comfort perception and tissue damage when wearing a facemask

  2026cites this paper
• Type 2 Myocardial Infarction: Navigating Diagnostic Pathways and Therapeutic Crossroads Between Invasive and Conservative Strategies

  2026cites this paper
• Myocardial ischemia: no supply/demand mismatch but reduced blood flow per beat.

  2026cites this paper
• Comparison of coronary artery calcium score-based and all-coronary computed tomography angiography strategies in patients with stable chest pain and risk factor-weighted clinical likelihood of 5-15.

  2026cites this paper
• The impact of pullback measurement on treatment decision in significant coronary artery disease: Insights from a retrospective multicentric study.

  2026cites this paper
• Physiology‐ versus angiography‐guided percutaneous coronary intervention for people with coronary artery disease

  2026cites this paper
• Efficacy of Yuxintong capsule on cardiorespiratory fitness in patients with stable coronary heart disease: a multicentre, randomized, double-blind, placebo-controlled, parallel-group clinical trial.

  2026cites this paper
• Invasive and medical management approaches to non-acute myocardial ischaemic syndromes.

  2026cites this paper
• Are ORBITA trials practice-changing?

  2025cites this paper
• Contemporary Antianginal Therapy

  2025cites this paper
• Optimal Medical Treatment Versus Percutaneous Coronary Intervention in Chronic Coronary Syndrome

  2025cites this paper
• Insurer Coverage of Invasive Coronary Angiography and Percutaneous Coronary Intervention for Stable Coronary Artery Disease Compared With Guidelines and Landmark Trials in the United States.

  2025cites this paper
• Changes in coronary disease management decisions in real-world practice between 2015 and 2023: insights from the EVAREST/BSE-NSTEP observational study

  2025cites this paper
• Chronic Coronary Artery Disease.

  2025cites this paper
• Reproducibility, Accuracy, and Treatment Impact of Ischemia Severity Assessment From Coronary Angiography　― An ORBITA Study Analysis ―

  2025cites this paper
• Coronary Intravascular Imaging: A Comprehensive Review of Techniques, Applications, and Future Directions

  2025cites this paper
• Percutaneous coronary intervention, coronary artery bypass grafting and mortality from acute myocardial infarction in EU15+ countries, 2006–2020: a secondary analysis of the OECD database

  2025cites this paper
• Intersection of Payer Coverage Policies and Clinical Care: Striking the Right Balance in Cardiovascular Medicine.

  2025cites this paper
• Innovations in Diagnosis and Treatment of Coronary Artery Disease

  2025cites this paper
• Optimal medical therapy for initial management of stable angina: a call to action.

  2025cites this paper
• Left Main Disease: The Last Frontier for Medical Therapy in Stable Coronary Artery Disease?

  2025cites this paper
• Diffuse coronary artery disease leads to deferral of both surgical and percutaneous coronary artery revascularisation.

  2025cites this paper
• Coronary Artery Revascularization in the Older Adult Population: A Scientific Statement From the American Heart Association.

  2025cites this paper
• Key Messages and Critical Approach of the 2024 Guidelines of the European Society of Cardiology on Chronic Coronary Syndromes.

  2025cites this paper
• Percutaneous Coronary Intervention for Heart Failure due to Coronary Artery Disease.

  2025cites this paper
• Clinical impact of CCT-FFR as first-strategy in patients with symptomatic stable coronary artery disease: A systematic review and meta-analysis.

  2025cites this paper
• Management of Angina Pectoris.

  2025cites this paper
• The Role of the Collateral Circulation in Stable Angina: An Invasive Placebo-Controlled Study

  2025cites this paper
• Coronary Intervention: History and Current Status

  2025cites this paper
• Young ERC Masterclass journal club article: the TOMAHAWK trial

  2025cites this paper
• Vascular (dys)function in the failing heart

  2025cites this paper
• Predictive value of the average three-vessel microvascular resistance in patients with non-ST-segment elevation myocardial infarction after percutaneous coronary intervention.

  2025cites this paper
• Multimodality Imaging for Diagnosis of Ischemic Heart Disease in Latin American Women from IAEA (International Atomic Energy Agency) Collaboratory

  2025influential citation
• British Cardiovascular Society/British Heart Foundation/British Atherosclerosis Society/British Society for Cardiovascular Research Young Investigator Award 2025

  2025cites this paper
• Magnetocardiography's role in a recurrent angina patient following percutaneous coronary intervention - Case report.

  2025cites this paper
• Pulsed field ablation vs sham ablation to treat atrial fibrillation (the PFA-SHAM trial)

  2025cites this paper
• Assessment of Microvascular Function in Angina Pectoris by Angiography-Based Index of Microcirculation Resistance: A Meta-Analysis

  2025cites this paper
• Sham-controlled trials and the future of electrophysiology: Reflections on SHAM-PFA

  2025cites this paper
• Medical management vs PCI in patients with stable angina: An updated systematic review and meta-analysis.

  2025cites this paper
• Long-acting nitrate use before and after revascularization to evaluate angina in chronic coronary syndrome: a case-crossover study from SCAAR

  2025cites this paper
• Equity at the Intersection of Heart Failure and Interventions: A Review of the Spectrum From Ambulatory Care to Cardiogenic Shock

  2025cites this paper
• Natural history and outcomes of medically treated coronary artery disease: insights from reconstructed individual patient data of 29 randomized trials.

  2025cites this paper
• Coronary microvascular dysfunction: pathophysiology, diagnosis, and therapeutic strategies across cardiovascular diseases

  2025cites this paper
• The Pullback Pressure Gradient

  2025cites this paper
• Moving with the flow.

  2025cites this paper
• Cost-effectiveness of stress echocardiography and exercise tolerance tests as screening in asymptomatic adults before starting physical activity

  2025cites this paper
• Temporal changes in PET myocardial flow reserve: implications for cardiovascular outcomes.

  2025cites this paper
• Shared Decision-Making in Chronic Stable Angina and Severe Aortic Stenosis.

  2025cites this paper
• Angina in stable coronary artery disease: Data from ORBITA and ORBITA-2.

  2025cites this paper
• Evidence of Benefit for Chronic Total Occlusion Revascularization From ISCHEMIA: New Road or Dead End?

  2025cites this paper
• Evaluation of Payer Policies to Reduce Low-Value Medical Device–Based Procedure Use

  2025cites this paper
• The future of cardiac repair: a review on cell-free nanotherapies for regenerative myocardial infarction

  2025cites this paper
• Surgically based therapies in heart failure: implications for patients and nursing practice.

  2025cites this paper
• Effect of rapamycin-eluting stents on in-stent restenosis and early inflammatory response in coronary artery narrowing animal models

  2025cites this paper
• Acupuncture combined with multiple therapies for angina pectoris: a systematic review and network meta-analysis

  2025cites this paper
• Redefining the Rules of Revascularization: Lessons From ISCHEMIA for the Future of Appropriate Use Criteria.

  2025cites this paper
• The History of Angina and Its Remedies: COURAGE, ORBITA, and a Path Forward.

  2025cites this paper
• Chronic coronary syndrome in Africa: current management and service challenges, and opportunities for optimizing patient care.

  2025cites this paper
• Rationale and Design of the ILIAS ANOCA Clinical Trial: a blinded-arm controlled trial for routine ad-hoc coronary function testing.

  2025cites this paper
• Definitions and standardized endpoints for the use of drug-coated balloon in coronary artery disease: consensus document of the Drug Coated Balloon Academic Research Consortium

  2025cites this paper
• What Is New in Risk Assessment in Nuclear Cardiology?

  2025cites this paper
• The Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma.

  2025cites this paper
• Systemic coagulation-inflammation index in the prediction of ISR in patients undergoing drug-eluting stents implant: A retrospective study based on multiple machine learning methods.

  2025cites this paper
• Definitions and standardized endpoints for the use of drug-coated balloon in coronary artery disease: consensus document of the Drug Coated Balloon Academic Research Consortium.

  2025cites this paper
• The role of cardiac imaging in the post-ISCHEMIA world

  2025cites this paper
• Effectiveness and Tolerability of Trimetazidine 80 mg Once Daily in Patients with Chronic Coronary Syndrome in Brazil: The V-GOOD Observational Study

  2025cites this paper
• Ischemia on Dobutamine Stress Echocardiography Predicts Efficacy of PCI: Results From the ORBITA-2 Trial.

  2025cites this paper
• Pulmonary Vein Isolation versus SHAM-pulmonary vein isolation for symptomatic relief in patients with Atrial Fibrillation - design and rationale of the PVI-SHAM-AF trial.

  2025cites this paper
• Coronary CT angiography for guiding PCI-Or no revascularization at all.

  2025cites this paper
• Management of Coronary Artery Disease in the Context of Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-analysis of Percutaneous Coronary Intervention Timing and an Algorithmic Approach to Management

  2025cites this paper
• Exploring the feasibility of using artificial intelligence to simulate the placebo arm of randomized clinical trials.

  2025cites this paper
• Impact of Percutaneous Coronary Interventions (PCIs) on Health Outcomes from a Jordanian Patient’s Perspective

  2025cites this paper
• Sustained Improvement in Quality of Life Following Catheter Ablation for Persistent AF Beyond 3 Years: That's No Sham.

  2025cites this paper
• Impact of an interactive CTCA/FFRCT interventional stent planning tool on patient management

  2025cites this paper
• Revascularization in Stable Coronary Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

  2025cites this paper
• How Different is Invasive Coronary Physiology in the Left Anterior Descending Artery?

  2025cites this paper
• Prognostic value of stress cardiovascular magnetic resonance in patients with ischaemic heart disease and severely reduced left ventricular ejection fraction

  2025cites this paper
• Health Status Outcomes With Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting in ISCHEMIA.

  2025cites this paper
• Symptoms, coronary artery disease and percutaneous coronary intervention: connecting the dots

  2025cites this paper
• Coronary Artery Disease and Severe Aortic Stenosis: Contemporary Treatment Options for Patients Undergoing Transcatheter Aortic Valve Implantation

  2024cites this paper
• Angioplastie coronaire dans le syndrome coronaire chronique : un changement de paradigme ?

  2024cites this paper
• Calcific versus non-calcific plaque: a CAD-RADS and FFRCT study

  2024cites this paper
• A simple blinding index for randomized controlled trials

  2024cites this paper
• Controversias en la revascularización y el estudio de viabilidad miocárdica en el síndrome coronario crónico

  2024cites this paper
• Medical Therapy Alone, Percutaneous Coronary Intervention, or Coronary Artery Bypass Grafting for Treatment of Coronary Artery Disease.

  2024cites this paper
• Left main coronary artery disease-cardiac CT's ticket to fame.

  2024cites this paper
• Traditional Chinese medicine for cardiovascular disease: efficacy and safety

  2024cites this paper
• Allopurinol versus Trimetazidine for the Treatment of Angina: A Randomized Clinical Trial

  2024cites this paper
• Cardiovascular Computed Tomography and Magnetic Resonance Imaging Guideline of the Brazilian Society of Cardiology and the Brazilian College of Radiology - 2024.

  2024cites this paper
• UHPLC-Q-Orbitrap HRMS and network analysis to explore the mechanisms of QiShenYiQi dripping pill for treating myocardial infarction

  2024cites this paper
• Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Coronary Artery Disease

  2024cites this paper
• Theoretical study of star shaped benzotriindole based variant non-fullerene acceptors for efficient organic solar cells

  2024cites this paper
• Experimental validation of coronary stenosis severity and development of ischemic myocardium.

  2024cites this paper
• ORBITA-2 confirms PCI effective for symptom relief in patients with stable angina 

  2024cites this paper
• Fondamentaux de l’évaluation des thérapeutiques, médicamenteuses et non médicamenteuses – un cadre pour l’évaluation des processus d’autoguérison

  2024cites this paper
• Percutaneous coronary intervention versus medical therapy in stable angina: a matched cohort study

  2024cites this paper
• Cutting the queue: the need for evidence‐driven surgery

  2024cites this paper